Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Facilitated thrombolysis: dethrombosis?

Héctor Luciardi1, Sofía Berman, Juan Muntaner

  • 1Curso Superior de Médico Cardiólogo and Magíster on Thrombosis, Facultad de Medicina, Universidad Nacional de Tucumán, Argentina. hectorlucas@sinectis.com.ar

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|July 18, 2002
PubMed
Summary

Dethrombosis strategies like antifibrin, antiplatelet, and defibrinogenation aim to dissolve intracoronary thrombi. Early application may aid reperfusion in acute myocardial infarction, particularly with percutaneous coronary intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.

Thrombosis research·2022
Same author

Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT)

Archivos de cardiologia de Mexico·2021
Same author

[Pulmonary thromboembolism and aortic dissection: an infrequent presentation].

Medicina·2017
Same author

[Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus].

Medicina·2016
Same author

[Takayasu's arteritis in a Caucasian man].

Medicina·2016
Same author

Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs.

Thrombosis journal·2015

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Intracoronary thrombus formation involves platelet aggregation and fibrin formation, with fibrinogen being crucial.
  • Dethrombosis offers a less aggressive alternative to potent fibrinolytic therapies for recent thrombi.

Purpose of the Study:

  • To explore the potential of dethrombosis strategies (antifibrin, antiplatelet, defibrinogenation) in facilitating reperfusion.
  • To evaluate the role of glycoprotein receptor antagonists in acute myocardial infarction reperfusion.

Main Methods:

  • Review of therapeutic approaches for intracoronary thrombus dissolution.
  • Analysis of the mechanisms of action for antifibrin, antiplatelet, and defibrinogenation agents.
  • Assessment of clinical data regarding reperfusion in acute myocardial infarction.

Related Experiment Videos

Main Results:

  • Glycoprotein receptor antagonists show promise in percutaneous transluminal coronary angioplasty but require further study in acute myocardial infarction.
  • Early implementation of dethrombosis strategies may enhance fibrinolysis and primary angioplasty.
  • Clinical benefits of facilitated thrombolysis have been limited, except in primary percutaneous coronary intervention patients.

Conclusions:

  • Dethrombosis strategies have theoretical benefits for reperfusion in acute myocardial infarction.
  • Further research is needed to establish the clinical efficacy of these less aggressive approaches.
  • Primary percutaneous coronary intervention appears to be a key setting for observing benefits of facilitated thrombolysis.